These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2030808)

  • 1. Serotonin, hypertension and vascular disease.
    Vanhoutte PM
    Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of serotonin and ischemia.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S15-9. PubMed ID: 1369711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived serotonin, the endothelium, and cardiovascular disease.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S6-12. PubMed ID: 1717775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
    Vanhoutte PM
    Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of serotonin.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S8-11. PubMed ID: 2446079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing and contracting factors.
    Vanhoutte PM; Eber B
    Wien Klin Wochenschr; 1991; 103(14):405-11. PubMed ID: 1926867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial dysfunction and vascular pathology].
    Vanhoutte PM
    Bull Mem Acad R Med Belg; 2006; 161(10-12):529-36; discussion 536-7. PubMed ID: 17503729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and vascular disease.
    Vanhoutte PM; Shimokawa H; Tang EH; Feletou M
    Acta Physiol (Oxf); 2009 Jun; 196(2):193-222. PubMed ID: 19220204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The endothelium and arterial reactivity].
    Vanhoutte PM
    J Mal Vasc; 1986; 11(3):213-21. PubMed ID: 3490530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
    Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet serotonin-LDL interaction in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S35-40. PubMed ID: 1717771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin, endothelin receptors, and endothelin antagonists.
    Lüscher TF
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):92-8. PubMed ID: 7850417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
    Tschudi MR; Lüscher TF
    Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.